Fig. 3From: Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumoniaKaplan–Meier cumulative event rates for the composite event during the therapeutic periodBack to article page